Skip to main content
Clinical Trials/PACTR202404915122192
PACTR202404915122192
Completed
Phase 4

A comparative study to evaluate the efficacy and tolerability of new generations of iron preparations with traditional iron therapy in pediatrics: A prospective randomized controlled trial.

Menoufia faculty of medicine0 sites87 target enrollmentFebruary 19, 2024

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Haematological Disorders
Sponsor
Menoufia faculty of medicine
Enrollment
87
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Menoufia faculty of medicine

Eligibility Criteria

Inclusion Criteria

  • Age range 6 months till 59 months old
  • no evidence of infection and negative c–reactive protein (CRP)
  • hemoglobin below the WHO stipulated cutoff values to define IDA anemia: hemoglobin \<11\.0 g/dL, MCV \<73 fL and serum ferritin \< 12 mg/L.
  • no history of consumption of iron supplements for 4 months ago or history of blood transfusion.

Exclusion Criteria

  • Children who had any signs of infection (fever, vomiting or diarrhea) on blood collection days,
  • children with anemia rather than IDA e.g. hemolytic anemia or haemoglobinopathy (sickle cell disease, beta thalassemia major)
  • children with chronic diseases or drugs that may affect iron absorption

Outcomes

Primary Outcomes

Not specified

Similar Trials